Abstract
Decision paralysis (DP) can be defined as a patient’s inability to commit to a physician and/or initiate appropriate treatment for their condition. An incessant search for greater physician opinions often leads to treatment delay, disease progression, and initiation of care at more advanced stages. Despite the harms associated with DP, a dearth of research on the issue remains. There are no guidelines that assist in both recognition and rectification of DP, leaving patients with chronic illnesses and diagnoses without well-characterized treatment algorithms especially vulnerable. This paper analyzes why patients are inclined toward DP and the clinical implications. Review of the literature affirms that the patient–physician relationship holds considerable influence; physicians identifying DP can improve therapeutic outcomes for their patients. Using these findings, we then propose a framework for broaching this topic with a method that supports patients while respecting their autonomy. A practical approach to both recognition and patient-centered discourse is introduced, providing a foundation for physicians to host these conversations and understand their patients’ perspectives. This approach toward recognition and discourse on DP holds clinical importance, given that there is a paucity of established guidance. A future uniform approach may generate optimal patient care recommendations, which will hold far-reaching impact on both the patient–physician relationship and overall patient outcomes.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Decision paralysis (DP) is an increasingly recognized phenomenon by which patients are unable to choose one physician and/or initiate appropriate treatment. |
When patients experience DP, they often undergo a search for second opinions which may result in initiating care at more advanced stages with more aggressive interventions than initially warranted. |
There is a scarcity of research on DP, with no guidelines to enable recognition and rectification—especially for diagnoses that do not possess clear, established treatment algorithms. |
Physicians may begin to address this issue with their patients in a supportive manner by employing our described patient-centered framework for discourse. |
Identifying DP can foster patient–physician collaboration and streamline plans for longitudinal treatment, potentially improving the patient’s prognosis and lived experience. |
Introduction
A patient recently arrived at our clinic to follow up on his diagnosis of cutaneous T-cell lymphoma (CTCL). His visits to our clinic have been sporadic, as we are the sixth specialist team that he has sought for second opinion. This “specialist-seeking” approach has led him to top physicians in New York City, the Northeast, and even internationally. Three years following initial diagnosis, he has yet to commit to one physician for continuous care and meaningful treatment of his cancer.
His story strikes as an unfortunate example of decision paralysis (DP), an increasingly recognizable phenomenon observed in several of our patients diagnosed with this rare cancer and other chronic diseases. It can be defined as an inability to choose one physician and/or initiate appropriate treatment. An incessant search for second and third opinions delays treatment, allowing for disease progression and thus leading to more aggressive interventions than initially warranted. For example, our patient’s 3-year treatment delay is regrettably accompanied by disease progression: he now has Sézary syndrome, an aggressive leukemic form of CTCL. Initiating care at this advanced stage greatly limits his options and worsens his overall prognosis. In an effort to tightly manage his care, the patient had ironically relinquished much of the control to the disease.
The patient–physician relationship holds considerable influence on patient well-being and can alleviate traumatic aspects of decision-making. Despite the prevalence of DP among patients suffering from oncologic or chronic conditions, there are no guidelines that enable recognition and rectification of this condition; this is particularly relevant for conditions without clear, established treatment algorithms. This practical approach highlights the issue of DP, empowering physicians to act through recognition and patient-centered discourse framework informed by narrative literature review. Identifying DP and intervening through discussion can foster patient–physician collaboration and streamline longitudinal treatment, potentially improving both the patient’s prognosis and lived experience.
Medical Ethics and Origins of DP
Normative medical ethics shifted ownership of medical decision-making [1] away from being paternalistic, borne exclusively by physicians [2]. Medical ethics introduced the concept of patient autonomy by acknowledging the clear violation of patient dignity and human rights [1, 3]. The World Medical Association’s International Code of Medical Ethics declares patient autonomy as treatment decisions primarily made by the informed patient [4]. More recently, the World Psychiatric Association issued The Madrid and The Kobe Declarations, affirming core values of mutual respect and cooperation [5, 6]. This introduced the third perspective of reciprocity, promoting shared decision-making among patients, families, and close contacts.
Allowing for these rights and encouraging patient dignity is a liberty that should certainly be celebrated; however, with such freedom often comes the increasing potential of further deliberation and subsequent delays in treatment. As American psychologist Barry Schwartz argues in his book The Paradox of Choice: Why More Is Less [7], the dramatic explosion in choice has paradoxically become a problem instead of a solution. Although considering many options and attempting to reach consensus among family members is with good intention, these unvarying discussions could easily reach a point of diminishing returns.
In addition to external influences, complex perceptive and emotional processes impact decision-making. A key component in analyzing DP is understanding why patients believe they need to search for these many opinions. For example, some patients may not appreciate the severity and time-sensitive nature of their disease: patients are more likely to delay treatment initiation if they do not experience a high “state of anxiety” upon diagnosis [8]. Additionally, patients with poor knowledge and comprehension of their cancer symptoms were found more likely to delay treatment. Furthermore, seeking a second opinion can empower patients grappling with a new, potentially life-threatening diagnosis [9,10,11,12,13]. However, this process may further contribute to indecision surrounding their condition. The assurance from seeking multiple physician opinions could easily lure patients toward an endless loop of answer-searching to no avail.
Recognition of DP
Recognition of patients experiencing DP is the first step toward improving therapeutic outcomes. DP is especially prevalent among patients with oncologic or chronic medical conditions. A noteworthy sign of DP is a sporadic pattern of physician intake visits, especially when occurring at multiple institutions. Moreover, it is not uncommon for patients to visit multiple specialists who collaborate with one another. Such specialists may even work together within organizational networks and research, particularly for treatment of rare conditions. This collaboration offers great potential for early recognition of DP.
If the patient–physician relationship is not a sufficient source of stability for the patients, DP can lead to what is colloquially known as “doctor-shopping behavior” (DSB) [14,15,16,17]. DSB can thus further impede initiation or continuation of treatment. DSB is not exclusive to the diagnostic stage, but rather has been shown to occur throughout treatment for hepatocellular carcinoma, for example [18]. A subsequent delay or postponement of decision, despite receiving similar physician opinions, should call physicians to action. It is therefore critical that physicians foster trusting and respectful relationships with their patients as they guide them through both the obstacles of their diagnosis and tendencies toward DP [19].
Call to Action: Toward Patient-Centered Discourse
With scarce research on DP, there are no guidelines to enable recognition and rectification of DP—especially for diagnoses without clear, established treatment algorithms. We aim to highlight this issue and propose a framework for supporting patients experiencing DP: an approach to discourse that will provide physicians a foundation upon which they can further build the conversation. This framework is informed by insights gleaned from clinical patient experiences and narrative literature review conducted through PubMed search (using this article’s keywords). This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
Moreover, the need for incorporating these discussion elements may change over time, in line with patients’ informational needs over the course of their disease [20]. Physicians should thus be prepared to host such discussions throughout the continuum of disease. Recognizing visit time constraints, physicians may choose to incorporate some or all proposed elements of discussion. With prospective examination of the phenomenon of DP, action can be made toward deriving optimal recommendations in the future.
Opening Conversation
Patient motivations for seeking a second opinion include perceived need for certainty or confirmation, lack of trust, communication dissatisfaction, and need for personalized information [10]. Space must first be held for this discussion during a clinical visit. After addressing a visit’s agenda, the physician may openly ask about perception of condition and care (Fig. 1A). Next, they may inquire about observing a history of recent outside clinic intake visits (Fig. 1B) with a frame of curiosity, rather than condemnation.
Eliciting Patient Perspective
Open elicitation of patient perspectives allows for understanding of intentions (Fig. 1C). It is important to patients with oncologic, rare, and/or chronic illnesses that their perspectives are heeded. Research shows perception of communication and treatment experiences influence the ways in which patients seek information [21]. This affects the information that patients seek, their comprehension, and need to seek information elsewhere to compensate. Repetition of the patient’s viewpoint ensures comprehension, allowing the patient to clarify any ambiguities or misunderstandings (Fig. 1D). This assurance encourages trust in the physician and the physician’s recommendations [21].
Meeting the Patient in Conversation
Next, the physician imparts perspective, potentially through engaging in “Q&A” (Fig. 1E, F). The physician may ask if the patient would like to learn about DP trends, its implications in prognosis, and options for DP-based care. Afterwards, the patient is welcomed to share any thoughts or inquiries (Fig. 1G). Research shows patient–physician communication during oncological second opinions can be insufficiently aligned, so effective communication and open discussion requires explicit support on managing expectations [22].
Steering and Support
Following physician input, the conversation is directed towards final thoughts (Fig. 1H). The patient expresses final wishes to proceed, highlighting a physician and/or plan for future care coordination. It is possible this conversation has not yet yielded final opinions; this is an opportunity to express continued support not contingent on any approach (Fig. 1I). Beyond clinical uncertainty and dissatisfaction, second opinion-seeking patients are also often influenced by family, friends, and online recommendations [23]. Open conversation allows the physician to gain insight into the patient’s individual situation and influences. The physician is therefore able to cater their suggestions to the patient’s unique circumstance, curbing further incidents of DP.
Action Items
Following discussion, action items may be formulated (Fig. 1J). This step is important for patients remaining in the decision-making process. For example, patients can outline different plans in the form of a list of pros and cons. The physician may assist with these action items, explaining available options and their pros and cons in a manner that promotes shared decision-making [24].
Follow-Up
Follow-up is ideally soon: patients should be encouraged to set a deadline for the chosen course, lessening risk of “loss to follow-up” (Fig. 1K). Future appointments may revisit the assigned action items to best direct the patient towards care.
Conclusion: A Balancing Act
Given the importance of patient autonomy, patient DP can be difficult to broach. In consideration of the ethical pillar of non-maleficence, physicians promptly raising discussion on DP is within the patient’s best interest. Communicating the gravity of the situation must be balanced with the patient’s ultimate freedom in decision-making. Physicians may begin to address this issue in a receptive manner by employing our described framework for discourse. This framework may serve as a foundation for generation of a future uniform approach, particularly for the treatment of conditions without well-defined treatment algorithms. Future studies may investigate this approach’s clinical implications within the patient–physician alliance, and assess its impact on patients experiencing DP throughout the continua of disease.
References
Pelto-Piri V, Engström K, Engström I. Paternalism, autonomy and reciprocity: ethical perspectives in encounters with patients in psychiatric in-patient care. BMC Med Ethics. 2013;14(1):49.
Coulter A. Partnerships with patients: the pros and cons of shared clinical decision-making. J Health Serv Res Policy. 1997;2(2):112–21.
Varkey B. Principles of clinical ethics and their application to practice. Med Princ Pract. 2021;30(1):17–28.
The World Medical Association. WMA International Code of Medical Ethics. https://www.wma.net/policies-post/wma-international-code-of-medical-ethics/. Accessed 22 Mar 2023.
Madrid Declaration. WPA. https://www.wpanet.org/current-madrid-declaration. Accessed 22 Mar 2023.
World Association of Social Psychiatry. Declarations. https://waspsocialpsychiatry.org/declarations/. Accessed 22 Mar 2023.
Schwartz B. The paradox of choice: why more is less. New York: Ecco; 2004.
Chojnacka-Szawłowska G, Majkowicz M, Basiński K, Zdun-Ryżewska A, Wasilewko I, Pankiewicz P. Knowledge of cancer symptoms and anxiety affect patient delay in seeking diagnosis in patients with heterogeneous cancer locations. Curr Probl Cancer. 2017;41(1):64–70.
Maruzzo M, La Verde N, Russo A, et al. Second medical opinion in oncological setting. Crit Rev Oncol Hematol. 2021;160:103282.
Hillen MA, Medendorp NM, Daams JG, Smets EMA. Patient-driven second opinions in oncology: a systematic review. Oncologist. 2017;22(10):1197–211.
Payne VL, Singh H, Meyer AND, Levy L, Harrison D, Graber ML. Patient-initiated second opinions: systematic review of characteristics and impact on diagnosis, treatment, and satisfaction. Mayo Clin Proc. 2014;89(5):687–96.
Greenfield G, Shmueli L, Harvey A, et al. Patient-initiated second medical consultations-patient characteristics and motivating factors, impact on care and satisfaction: a systematic review. BMJ Open. 2021;11(9):e044033.
Lehmann V, Smets EMA, de Jong M, et al. Reducing uncertainty: motivations and consequences of seeking a second opinion in oncology. Acta Oncol. 2020;59(12):1512–9.
Chao DVK. Doctor shopping. Hong Kong Med J. 2013;19(1):4–5.
Siu JYM. “Seeing a doctor is just like having a date”: a qualitative study on doctor shopping among overactive bladder patients in Hong Kong. BMC Fam Pract. 2014;6(15):27.
Ohira Y, Ikusaka M, Noda K, et al. Consultation behaviour of doctor-shopping patients and factors that reduce shopping. J Eval Clin Pract. 2012;18(2):433–40.
Sansone RA, Sansone LA. Doctor shopping: a phenomenon of many themes. Innov Clin Neurosci. 2012;9(11–12):42–6.
Hsieh CI, Chung KP, Yang MC, Li TC. Association of treatment and outcomes of doctor-shopping behavior in patients with hepatocellular carcinoma. Patient Prefer Adherence. 2013;7:693–701.
Williamson LD, Thompson KM, Ledford CJW. Trust takes two…. J Am Board Fam Med. 2022;35(6):1179–82.
Harris KA. The informational needs of patients with cancer and their families. Cancer Pract. 1998;6(1):39–46.
Adamson M, Choi K, Notaro S, Cotoc C. The doctor-patient relationship and information-seeking behavior: four orientations to cancer communication. J Palliat Care. 2018;33(2):79–87.
Lehmann V, Smets EMA, de Jong M, de Vos FYF, Stouthard JM, Hillen MA. Patient-provider communication during second opinion consultations in oncology. Patient Educ Couns. 2021;104(10):2490–7.
Shmueli L, Davidovitch N, Pliskin JS, Balicer RD, Hekselman I, Greenfield G. Seeking a second medical opinion: composition, reasons and perceived outcomes in Israel. Isr J Health Policy Res. 2017;6(1):67.
Stiggelbout AM, Pieterse AH, De Haes JCJM. Shared decision making: concepts, evidence, and practice. Patient Educ Couns. 2015;98(10):1172–9.
Acknowledgements
We thank the patients whose shared experiences informed this study.
Funding
No funding or sponsorship was received for this study or publication of this article.
Author Contributions
Conceptualization: Celine Schreidah, Larisa Geskin; Methodology: Celine Schreidah; Formal analysis and investigation: Celine Schreidah, Larisa Geskin; Writing-original draft preparation: Celine Schreidah; Writing-review and editing: Larisa Geskin, Celine Schreidah, Lauren Fahmy, Brigit Lapolla; Supervision: Larisa Geskin.
Disclosures
Larisa J. Geskin has served as an investigator for and/or received research support from Helsinn Group, J&J, Mallinckrodt, Kyowa Kirin, Soligenix, Innate, Merck, BMS, and Stratpharma; on the speakers’ bureau for Helsinn Group and J&J; and on the scientific advisory board for Helsinn Group, J&J, Mallinckrodt, Sanofi, Regeneron, and Kyowa Kirin. Celine M. Schreidah, Lauren M. Fahmy, and Brigit A. Lapolla have nothing to disclose.
Compliance with Ethics Guidelines
This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
Data Availability
Data sharing is not applicable to this article as no data sets were generated or analyzed during the current study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
About this article
Cite this article
Schreidah, C.M., Fahmy, L.M., Lapolla, B.A. et al. Decision Paralysis: Recognition and Patient-Centered Discourse. Dermatol Ther (Heidelb) 13, 1211–1217 (2023). https://doi.org/10.1007/s13555-023-00921-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13555-023-00921-3